Annet Kirabo Will Receive Hypertension Research Award
The American Heart Association will honor Dr. Kirabo in Arlington for her research on salt-sensitive blood pressure.
Updated on Sept. 21, 2026 in Heart Disease
On October 10, 2026, the American Heart Association and Sky Labs Inc. will present the Established Investigator Award for Clinical Hypertension to Dr. Annet Kirabo. This honor recognizes her pioneering identification of the immune mechanisms that drive hypertension.
Why it matters
Dr. Kirabo is being honored for her discovery of how oxidative stress and adaptive immunity contribute to high blood pressure. Her research provides critical insights into the immune drivers of cardiovascular disease.
Dr. Kirabo has authored 230 scientific publications throughout her career. It remains unknown how her specific identified immune pathways will be integrated into future clinical hypertension treatment protocols.
The players
Annet Kirabo
Dr. Kirabo is a Vanderbilt faculty member who specializes in functional genomics and the immune mechanisms of cardiovascular health.
American Heart Association
This nonprofit organization is dedicated to fighting cardiovascular disease and stroke through research, advocacy, and education.
Sky Labs Inc.
Sky Labs Inc. is a medical technology company based in South Korea that develops monitoring solutions for chronic cardiovascular conditions.
Vanderbilt University
Vanderbilt is a private research university in Nashville that hosts extensive programs in clinical health and genomic research.
ScholarGPS
ScholarGPS is an analytics platform that tracks and ranks the productivity and impact of academic researchers worldwide.
The details
Dr. Kirabo and her team at Vanderbilt have established clear links between salt-sensitive hypertension and specific immune responses. Her work continues to expand the understanding of how the body regulates blood pressure at a molecular level.
Timeline
Kirabo earned a PhD from the University of Florida in 2011.
Kirabo joined the Vanderbilt faculty in 2015.
Kirabo was named a Fellow of the American Heart Association in 2024.
ScholarGPS ranked Kirabo as a 2025 Top Scholar.
The award will be presented in Arlington on October 10, 2026.
The Big Picture
This award marks a significant milestone for the ongoing work produced by the Vanderbilt University cardiovascular physiology research program. Her achievements reflect the increasing focus on genomic and immune-system interactions in modern heart disease research.
This research provides a deeper understanding of the immune system's role in blood pressure, potentially leading to more targeted hypertension treatments. Patients may eventually see new clinical options that address these underlying biological drivers rather than just treating symptoms.
The takeaway
Dr. Kirabo's recognition highlights the importance of interdisciplinary studies linking veterinary science, genomics, and cardiology. This approach is increasingly vital for understanding complex chronic conditions that affect millions of individuals.
Further reading
Learn more about the latest research and clinical standards in Heart Disease.
Source note: This article includes information reported by The Tennessee Tribune.
